Impact of pharmaceutical care interventions in improving clinical outcomes among patients with pulmonary tuberculosis: a systematic review

References

• Carter, K. L., Gabrellas, A. D., Shah, S., & Garland, J. M. (2017). Improved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist. The International Journal of Tuberculosis and Lung Disease, 21(4), 432–437. https://doi.org/10.5588/ijtld.16.0575
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2022). How TB spreads. CDC. https://www.cdc.gov/tb/topic/basics/howtbspreads.htm
   Google Scholar
• Clark, P. M., Karagoz, T., Apikoglu-Rabus, S., & Izzettin, F. V. (2007). Effect of pharmacist-led patient education on adherence to tuberculosis treatment. American Journal of Health-System Pharmacy, 64(5), 497–505. https://doi.org/10.2146/ajhp050543
   PubMed Web of Science ®Google Scholar
• Falagas, M. E., Pitsouni, E. I., Malietzis, G. A., & Pappas, G. (2008). Comparison of PubMed, Scopus, Web of Science, and Google Scholar: Strengths and weaknesses. The FASEB Journal, 22(2), 338–342. https://doi.org/10.1096/fj.07-9492LSF
   PubMed Web of Science ®Google Scholar
• Haddaway, N. R., Page, M. J., Pritchard, C. C., & McGuinness, L. A. (2022). PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Systematic Reviews, 18(2), e1230. https://doi.org/10.1002/cl2.1230
   PubMedGoogle Scholar
• Hess, K., Goad, J., Wu, J., & Johnson, K. (2009). Isoniazid completion rates for latent tuberculosis infection among college students managed by a community pharmacist. Journal of American College Health, 57(5), 553–555. https://doi.org/10.3200/jach.57.5.553-556
   PubMed Web of Science ®Google Scholar
• Higgins, J. P. T., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., Savović, J., Schulz, K. F., Weeks, L., & Sterne, J. A. (2011). The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ, 343(2), Article d5928. https://doi.org/10.1136/bmj.d5928
   Google Scholar
• Iskandar, D., Suryanegara, F. D. A., van Boven, J. F. M., & Postma, M. J. (2023). Clinical pharmacy services for tuberculosis management: A systematic review. Frontiers in Pharmacology, 14, Article 1186905. https://doi.org/10.3389/fphar.2023.1186905
   PubMed Web of Science ®Google Scholar
• Jakeman, B., Logothetis, S. J., Roberts, M. H., Bachyrycz, A., Fortune, D., Borrego, M. E., Ferreira, J., & Burgos, M. (2020). Addressing latent tuberculosis infection treatment through a collaborative care model with community pharmacies and a health department. Preventing Chronic Disease, 17, E14. https://doi.org/10.5888/pcd17.190263
   PubMed Web of Science ®Google Scholar
• Jones, J. M. (2011). Record 64% rate honesty, ethics of members of congress low: Ratings of nurses, pharmacists, and medical doctors most positive. Gallup. https://news.gallup.com/poll/151460/record-rate-honesty-ethics-members-congress-low.aspx
   Google Scholar
• Juan, G., Lloret, T., Perez, C., Lopez, P., Navarro, R., Ramón, M., Cortijo, J., & Morcillo, E. J. (2006). Directly observed treatment for tuberculosis in pharmacies compared with self-administered therapy in Spain. The International Journal of Tuberculosis and Lung Disease, 10(2), 215–221.
   PubMed Web of Science ®Google Scholar
• Karuniawati, H., Putra, O. N., & Wikantyasning, E. R. (2019). Impact of pharmacist counseling and leaflet on the adherence of pulmonary tuberculosis patients in lungs hospital in Indonesia. Indian Journal of Tuberculosis, 66(3), 364–369. https://doi.org/10.1016/j.ijtb.2019.02.015
   PubMedGoogle Scholar
• Lara-Júnior, C. R., Ahouagi, A. E. O., Pinto, I. V. L., Braga, D. G., Andrade, T. R., Ramalho-de-Oliveira, D., & Nascimento, M. M. G. D. (2022). Implementation and effectiveness of a pharmacotherapeutic follow-up service for people with tuberculosis in primary healthcare. International Journal of Environmental Research and Public Health, 19(21), 14552. https://doi.org/10.3390/ijerph192114552
   PubMed Web of Science ®Google Scholar
• Lopes, A., Miranda, S., Ceccato, M., Silveira, M., Resende, N., & Carvalho, W. (2017). Evaluation of the impact of pharmaceutical care for tuberculosis patients in a Secondary Referral Outpatient Clinic, Minas Gerais, Brazil. Anais da Academia Brasileira de Ciências, 89(4), 2911–2919. https://doi.org/10.1590/0001-3765201720170301
   PubMed Web of Science ®Google Scholar
• Manolakis, P. G., & Skelton, J. B. (2010). Pharmacists’ contributions to primary care in the United States collaborating to address unmet patient care needs: The emerging role for pharmacists to address the shortage of primary care providers. American Journal of Pharmaceutical Education, 74(10), S7. https://doi.org/10.5688/aj7410s7
   PubMedGoogle Scholar
• Miller, R., & Goodman, C. (2020). Quality of tuberculosis care by pharmacies in low- and middle-income countries: Gaps and opportunities. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 18, Article 100135. https://doi.org/10.1016/j.jctube.2019.100135
   PubMedGoogle Scholar
• Moadebi, S., Stark, G., Elwood, R. K., White, R., & Marra, F. (2005). Patient satisfaction with antituberculosis medication counselling: A comparison of services provided by pharmacists and nurses. The Canadian Journal of Hospital Pharmacy, 58(3), 136–141.
   Google Scholar
• Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews, 4(1), 1. https://doi.org/10.1186/2046-4053-4-1
   PubMed Web of Science ®Google Scholar
• National Institute of Health. (2013). Study quality assessment tools. NIH. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
   Google Scholar
• Nowak, R. (1995). WHO calls for action against TB. Science, 267(5205), 1763. https://doi.org/10.1126/science.7892595
   PubMed Web of Science ®Google Scholar
• Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016). Rayyan – a web and mobile app for systematic reviews. Systematic Reviews, 5(1), 210–220. https://doi.org/10.1186/s13643-016-0384-4
   PubMedGoogle Scholar
• Pradipta, I. S., Yanuar, E. O., Nurhijriah, C. Y., Maharani, N. P., Subra, L., Destiani, D. P., & Diantini, A. (2023). Practical models of pharmaceutical care for improving tuberculosis patient detection and treatment outcomes: A systematic scoping review. Tropical Medicine and Infectious Disease, 8(5), 287. https://doi.org/10.3390/tropicalmed8050287
   PubMedGoogle Scholar
• RAND Corporation. Visit-specific satisfaction instrument (VSQ-9). RAND. https://www.rand.org/health-care/surveys_tools/vsq9.html
   Google Scholar
• Tang, Z. Q., Jiang, R. H., & Xu, H. B. (2018). Effectiveness of pharmaceutical care on treatment outcomes for patients with first-time pulmonary tuberculosis in China. Journal of Clinical Pharmacy and Therapeutics, 43(6), 888–894. https://doi.org/10.1111/jcpt.12746
   PubMed Web of Science ®Google Scholar
• Tanvejsilp, P., Pullenayegum, E., Loeb, M., Dushoff, J., & Xie, F. (2017). Role of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand. Journal of Clinical Pharmacy and Therapeutics, 42(3), 337–344. https://doi.org/10.1111/jcpt.12519
   PubMed Web of Science ®Google Scholar
• Tavitian, S. M., Spalek, V. H., & Bailey, R. P. (2003). A pharmacist-managed clinic for treatment of latent tuberculosis infection in health care workers. American Journal of Health-System Pharmacy, 60(18), 1856–1861. https://doi.org/10.1093/ajhp/60.18.1856
   PubMed Web of Science ®Google Scholar
• Thomas, A., Joy, J., Kurian, A., & Sivakumar, V. (2018). Socio-epidemiological evaluation of tuberculosis and impact of pharmaceutical care on medication adherence among tuberculosis patients. Asian Journal of Pharmaceutical and Clinical Research, 11(2), 265–268. https://doi.org/10.22159/ajpcr.2018.v11i2.20503
   Google Scholar
• Tsuyuki, R. T., Beahm, N. P., Okada, H., & Al Hamarneh, Y. N. (2018). Pharmacists as accessible primary health care providers: Review of the evidence. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 151(1), 4–5. https://doi.org/10.1177/1715163517745517
   Google Scholar
• Wong, Y. J., Ng, K. Y., & Lee, S. W. H. (2023). Community pharmacists-led interventions in tuberculosis care: A systematic review. Research in Social and Administrative Pharmacy, 19(1), 5–15. https://doi.org/10.1016/j.sapharm.2022.09.001
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2010). Treatment of tuberculosis: Guidelines (4th ed.). WHO. https://apps.who.int/iris/handle/10665/44165
   Google Scholar
• World Health Organization. (2021a). Global tuberculosis report 2021. WHO. https://www.who.int/publications/digital/global-tuberculosis-report-2021/tb-disease-burden/incidence
   Google Scholar
• World Health Organization. (2021b). New WHO recommendations issued to improve access to rapid molecular tests for the detection of TB and drug-resistant TB. WHO. https://www.who.int/news/item/07-07-2021-new-who-recommendations-issued-to-improve-access-to-rapid-molecular-tests-for-the-detection-of-tb-and-drug-resistant-tb
   Google Scholar
• World Health Organization. (2022). Tuberculosis, key facts. WHO. https://www.who.int/news-room/fact-sheets/detail/tuberculosis
   Google Scholar
• World Health Organization, International Pharmaceutical Federation. (2011). The role of pharmacists in tuberculosis care and control India. WHO, FIP. https://www.fip.org/files/fip/WHO/Signing%20ceremony_WHOFIPJointStatement.pdf
   Google Scholar
• Wright, J., Walley, J., Philip, A., Pushpananthan, S., Dlamini, E., Newell, J., & Dlamini, S. (2004). Direct observation of treatment for tuberculosis: A randomized controlled trial of community health workers versus family members. Tropical Medicine & International Health, 9(5), 559–565. https://doi.org/10.1111/j.1365-3156.2004.01230.x
   PubMed Web of Science ®Google Scholar
• Zhang, H., Ehiri, J., Yang, H., Tang, S., & Li, Y. (2016). Impact of community-based DOT on tuberculosis treatment outcomes: A systematic review and meta-analysis. PLoS One, 11(2), e0147744. https://doi.org/10.1371/journal.pone.0147744
   PubMed Web of Science ®Google Scholar
• Zvavamwe, Z., & Ehlers, V. J. (2009). Experiences of a community-based tuberculosis treatment programme in Namibia: A comparative cohort study. International Journal of Nursing Studies, 46(3), 302–309. https://doi.org/10.1016/j.ijnurstu.2008.09.013
   PubMed Web of Science ®Google Scholar